ArticleClinical proteomics2023

Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics.

Hanneke van der Wijngaart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.